ORCID as entered in ROS

Select Publications
2015, 'Radial versus femoral access for cardiac catheterisation - Authors' reply.', Lancet, 386, pp. 2394, http://dx.doi.org/10.1016/S0140-6736(15)01198-8
,2015, 'Radial versus femoral access for cardiac catheterisation', Lancet, 386, pp. 2392, http://dx.doi.org/10.1016/S0140-6736(15)01195-2
,2015, 'Initial clinical results of the REDUCE LAP-HF TRIAL (REDUCE elevated left atrial pressure in patients with heart failure trial)', EUROPEAN JOURNAL OF HEART FAILURE, 17, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000366200402025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Late surgical explantation and aortic valve replacement after transcatheter aortic valve implantation', Annals of Thoracic Surgery, 99, pp. 1434 - 1436, http://dx.doi.org/10.1016/j.athoracsur.2014.06.099
,2015, 'Mid-term Outcomes in patients following transcatheter aortic valve implantation in the corevalve Australia and New Zealand study', Heart Lung and Circulation, 24, pp. 281 - 290, http://dx.doi.org/10.1016/j.hlc.2014.09.023
,2015, 'Position statement for the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program', Heart Lung and Circulation, 24, pp. 219 - 223, http://dx.doi.org/10.1016/j.hlc.2014.09.009
,2015, 'Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation', Interventional Cardiology Reviews Research Resources, 10, pp. 49 - 54, http://dx.doi.org/10.15420/icr.2015.10.1.49
,2015, 'Effect of cardiac output measurement error in the calculation and interpretation of cardiac output-derived haemodynamic variables in the cardiac catheterisation laboratory', Heart, Lung and Circulation, 24, pp. S371 - S371, http://dx.doi.org/10.1016/j.hlc.2015.06.603
,2014, 'Renal artery stenosis following renal percutaneous denervation', Catheterization and Cardiovascular Interventions, 84, pp. 1180 - 1183, http://dx.doi.org/10.1002/ccd.25546
,2014, 'Radiation dose during percutaneous treatment of structural heart disease', Heart Lung and Circulation, 23, pp. 1075 - 1083, http://dx.doi.org/10.1016/j.hlc.2014.04.258
,2014, 'The MitraClip experience and future percutaneous mitral valve therapies', Heart Lung and Circulation, 23, pp. 1009 - 1019, http://dx.doi.org/10.1016/j.hlc.2014.05.021
,2014, 'Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: Results of the Coherex-EU study', Catheterization and Cardiovascular Interventions, 83, pp. 1135 - 1143, http://dx.doi.org/10.1002/ccd.24565
,2014, 'Pulmonary artery stent for bronchial adenoid cystic carcinoma causing pulmonary artery stenosis', Respirology Case Reports, 2, pp. 39 - 41, http://dx.doi.org/10.1002/rcr2.42
,2014, 'Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension', Journal of the American College of Cardiology, 63, pp. 611 - 618, http://dx.doi.org/10.1016/j.jacc.2013.11.022
,2014, 'A Clip in time - Selecting interventions for severe mitral valve regurgitation', Heart Lung and Circulation, 23, pp. 493 - 495, http://dx.doi.org/10.1016/j.hlc.2014.02.006
,2014, 'Delayed Amplatzer Occluder Device Closure of Postinfarction Ventricular Septal Defect: A Case Report', CASE REPORTS IN CARDIOLOGY, 2014, http://dx.doi.org/10.1155/2014/159010
,2014, 'Profile of St. Jude Medical's Allure Quadra quadripolar pacemaker system for cardiac resynchronization therapy', Expert Review of Medical Devices, 12, pp. 41 - 48, http://dx.doi.org/10.1586/17434440.2015.984686
,2014, 'Percutaneous mitral valve repair with the MitraClip: early results from the MitraClip Asia-Pacific Registry (MARS)', EuroIntervention, 10, pp. 620 - 625, http://dx.doi.org/10.4244/EIJV10I5A107
,2013, 'Role of bi-atrial pacing in slowing the progression of paroxysmal atrial fibrillation to permanent atrial fibrillation', Journal of Atrial Fibrillation, 6, pp. 34 - 38
,2013, 'The MitraClip Experience and Future Percutaneous Mitral Valve Therapies', Heart Lung and Circulation, http://dx.doi.org/10.1016/j.hlc.2014.05.021
,2012, 'Funding of new cardiac technologies in Australia', Medical Journal of Australia, 197, pp. 132 - 133, http://dx.doi.org/10.5694/mja12.10994
,2012, 'Inducible myocardial ischaemic diagnosed using computed tomography dipyridamole stress myocardial perfusion technique', Journal of Medical Imaging and Radiation Oncology, 56, pp. 445 - 448, http://dx.doi.org/10.1111/j.1754-9485.2012.02363.x
,2011, 'Guidelines for patient selection and performance of carotid artery stenting.', Intern Med J, 41, pp. 344 - 347, http://dx.doi.org/10.1111/j.1445-5994.2011.02445.x
,2010, 'Early Effectiveness and Safety Results From the CoreValve Transcatheter Aortic Valve Australia-New Zealand Study', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56, pp. B112 - B113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209824200487&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Long-term clinical outcomes with the next-generation Resolute Stent System: A report of the two-year follow-up from the RESOLUTE clinical trial', Eurointervention, 5, pp. 692 - 697, http://dx.doi.org/10.4244/EIJV5I6A114
,2010, 'Guidelines for patient selection and performance of carotid artery stenting.', ANZ J Surg, 80, pp. 398 - 405, http://dx.doi.org/10.1111/j.1445-2197.2010.05330.x
,2009, 'Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study', Catheterization and Cardiovascular Interventions, 74, pp. 989 - 995, http://dx.doi.org/10.1002/ccd.22206
,2009, 'Guidelines for patient selection and performance of carotid artery stenting', Journal of Medical Imaging and Radiation Oncology, 53, pp. 538 - 545, http://dx.doi.org/10.1111/j.1754-9485.2009.02120.x
,2008, 'Results of Percutaneous intervention in patients with Transplant Coronary Artery Disease: A Retrospective Analysis', Heart, Lung and Circulation, 17, pp. S180 - S180, http://dx.doi.org/10.1016/j.hlc.2008.05.427
,2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963
,2007, 'Long-Term Clinical Follow-up of Sirolimus-Eluting (CYPHER™) Coronary Stents in the Treatment of InStent Restenosis in an Unselected Population', Heart Lung and Circulation, 16, pp. 440 - 446, http://dx.doi.org/10.1016/j.hlc.2007.02.090
,2007, 'Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study', American Journal of Cardiology, 100, pp. S56 - S61, http://dx.doi.org/10.1016/j.amjcard.2007.08.023
,2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
,2007, 'Adaptive bi-atrial pacing improves the maintenance of sinus rhythm', PACE Pacing and Clinical Electrophysiology, 30, pp. 492 - 497, http://dx.doi.org/10.1111/j.1540-8159.2007.00698.x
,2007, 'Long-Term Follow-up of Renal Artery Stenting in an Australian Population', Heart Lung and Circulation, 16, pp. 79 - 84, http://dx.doi.org/10.1016/j.hlc.2006.12.008
,2007, 'The current status and future direction of percutaneous coronary intervention without on-site surgical backup: An expert consensus document from the Society for Cardiovascular Angiography and Interventions', Catheterization and Cardiovascular Interventions, 69, pp. 471 - 478, http://dx.doi.org/10.1002/ccd.21097
,2007, 'Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease', Journal of Molecular and Cellular Cardiology, 42, pp. 19 - 33
,2007, 'Clinical Follow-Up of Paclitaxel-Eluting (TAXUS) Sents for the Treatment of Saphenous Vein Graft Disease', Journal of Interventional Cardiology, 20 (4), pp. 258 - 264
,2007, 'Diagnostic Accuracy of CT Coronary Angiography Compared with Invasive Coronary Angiography: Initial Experience At St Vincent's Hospital, Sydney', Heart, Lung and Circulation, 16, pp. S55 - S55, http://dx.doi.org/10.1016/j.hlc.2007.06.141
,2006, 'Insertion of a Fenestrated Amplatzer Atrial Septostomy Device for Severe Pulmonary Hypertension', Heart Lung and Circulation, 15, pp. 275 - 277, http://dx.doi.org/10.1016/j.hlc.2006.02.002
,2006, 'Staged carotid artery stenting and coronary artery bypass graft surgery: Initial results from a single center', Catheterization and Cardiovascular Interventions, 67, pp. 142 - 148
,2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
,2005, 'First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.', Eurointervention, 1, pp. 157 - 164
,2005, 'Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures - A randomised controlled trial', Heart Lung and Circulation, 14, pp. 245 - 251, http://dx.doi.org/10.1016/j.hlc.2005.06.007
,2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B
,2005, 'Percutaneous carotid artery stenting: a strategy in evolution', Internal Medicine Journal, 35, pp. 143 - 150
,2005, 'Update on the use of stem cells for cardiac disease', Internal Medicine Journal, 35, pp. 348 - 356
,2004, 'Endeavor I `first in human` safety and efficacy study - 12-month clinical, angiographic, and intravascular ultrasound results', Circulation, 110, pp. 563 - 564
,2004, 'ENDEAVOR I safety and efficacy study: 12-month results', American Journal of Cardiology, 94, pp. 68E - 68E
,2004, 'HEART TRANSPLANT PATIENTS TREATED WITH SIROLIMUS IMMMUNOTHERAPY SHOW SIGNIFICANT REDUCTION IN THE PROGRESSION OF GRAFT VASCULOPATHY AT 2 YEARS', Transplantation, 78, pp. 160 - 160, http://dx.doi.org/10.1097/00007890-200407271-00421
,